Please login to the form below

Not currently logged in

Board member Engelbert Tjeenk Willink to leave Boehringer

Replaced by head of established markets Allan Hillgrove

Engelbert Tjeenk Willink, member of the board of managing directors at Boehringer Ingelheim responsible for marketing and sales of prescription medicines, is to leave the German pharma company at the end of 2012.

He will be replaced by current head of established markets Allan Hillgrove, who takes over from January 1, 2013.

Tjeenk Willink has been in his current role since 2009, having originally joined Boehringer in 1994 as a medical director. Other positions he has held during his time at the company include head of marketing and sales in Canada, head of marketing for prescription medicines and country manager of Boehringer in Mexico.

Boehringer - Engelbert Tjeenk WillinkBoehringer - Allan Hillgrove

Engelbert Tjeenk Willink (left) and Allan Hillgrove (right)

“We are sorry to see him go and wish him all the best in his future professional and personal life,” said Christian Boehringer, chair of the shareholders committee, and Professor Andreas Barner, chair of the board, in a joint statement.

“Tjeenk Willink has worked with passion and enthusiasm for Boehringer Ingelheim. In his various roles in Ingelheim and abroad, he contributed significantly to the positive development of the group.”

His replacement, Hillgrove, has been with Boehringer since 1982, and has been in his current role since 2010.

“In his various roles he has helped to set the course for sustained growth in recent years,” said Boehringer and Barner in their joint statement.

“Shareholders and board members are convinced that with this staffing arrangement the board of managing directors will be well equipped for the various challenges that lie ahead for Boehringer Ingelheim and the research-driven pharmaceutical industry worldwide."

28th September 2012

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

What is a patient-centric brand anyway?
It’s hard to believe that in our industry, there have been ongoing rumblings about patient-centricity for years now. Sure, there are some great companies who have worked hard to bring...
‘Less Is More: Making Patient-Centered Digital Communication a Reality’
Letizia Affinito writes on the Gower Publishing blog....
The Seven Cs Of Cross-Functional Brand Planning
As more and more organisations have moved to cross-functional and cross-regional involvement in the development of their strategic and operational brand plans, the result has been greater engagement and alignment,...